J&J says its Covid vaccine is 66% effective, but the single shot may fall short against variants

The Covid vaccine was well tolerated, with no significant safety concerns related to the vaccine reported, J&J said. There were also no reports of anaphylaxis.

from Health and Science https://ift.tt/2M8xq1I
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH